J. DE WALLEG LIMITED
Company number 01270092 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: J. DE WALLEG LIMITED
1. Financial Health Score: C+
Explanation: The patient is stable but exhibiting multiple symptoms of financial strain. While the company has demonstrated long-term resilience through consistent net asset growth over nine years, its vital signs reveal significant working capital pressure, heavy reliance on short-term debt, and liquidity constraints that leave limited room for unexpected shocks. The recent improvement in cash reserves is encouraging, but the underlying circulatory system (cash flow management) remains under stress.
2. Key Vital Signs
Blood Pressure – Leverage Ratio
Total Liabilities to Shareholders' Funds: 2.27:1
For every £1 of the owners' equity, the company carries £2.27 in liabilities. This is elevated for a manufacturing business. Think of this as high blood pressure – the system is under constant strain. A healthy ratio for this sector would typically be below 1.5:1.
Heart Rate – Current Ratio
Current Assets to Current Liabilities: 1.28:1
A reading of 1.28:1 means the company can just about cover its short-term obligations with its short-term assets. This is the bare minimum for a healthy pulse – any disruption to cash inflows or unexpected costs could quickly push this into dangerous territory. The ideal for manufacturing businesses is typically 1.5:1 or above.
Oxygen Saturation – Quick Ratio (Acid Test)
(Current Assets minus Stock) to Current Liabilities: 0.69:1
This is concerning. Excluding inventory (which takes time to convert to cash), the company only has 69p of liquid assets for every £1 of short-term debts. If suppliers demanded payment tomorrow, the company would struggle to meet obligations without selling stock – and stock is inherently less liquid than cash.
Temperature – Cash Position
Cash: £38,770 (up from £1,414 in 2025)
The fever has broken! After a dangerously low cash position in 2025 (£1,414 – virtually nil), the company has built reserves to £38,770. This is a significant recovery, though still modest for a business with £550,573 in current liabilities. The historical pattern shows volatile cash levels (ranging from £1,414 to £49,134), suggesting inconsistent cash flow management.
Cholesterol – Stock Levels
Stock: £328,578 (up 53% from £214,062)
Stock represents 46% of all current assets – this is a high concentration. The 53% year-on-year increase could indicate either: (a) preparation for anticipated demand growth, (b) slow-moving or obsolete inventory building up, or (c) production inefficiencies. Without turnover figures (the company filed under the small companies regime and didn't include a Profit & Loss account), we cannot calculate stock turnover, which limits our diagnostic capability.
Body Mass Index – Net Asset Growth
Net Assets: £243,041 (up from £122,458 over 9 years)
The company has nearly doubled its net worth over the past decade, growing from £122,458 in 2017 to £243,041 in 2026. This demonstrates a healthy underlying metabolism – the business is generating and retaining profits. This is the strongest vital sign in the assessment.
3. Diagnosis
Primary Condition: Chronic Working Capital Strain
The company is suffering from a persistent imbalance between its short-term obligations and its liquid resources. While the business is profitable (evidenced by growing retained earnings), too much capital is tied up in stock and debtors, and too much reliance is placed on creditors and bank facilities to fund operations.
Specific Symptoms Identified:
1. Over-reliance on Bank Overdrafts and Short-term Debt Bank loans and overdrafts total £157,628 within current liabilities, plus £6,833 in long-term loans. Overdrafts are typically repayable on demand, making this a fragile funding structure. The increase from £121,029 to £157,628 (30% rise) suggests growing dependence on bank facilities.
2. Significant Trade Creditor Pressure Trade creditors of £236,234 (up 12% from £210,320) represent the largest single creditor balance. This could indicate the company is extending payment terms to manage cash flow – effectively using suppliers as a funding source. This is a common but risky strategy that can damage supplier relationships.
3. Intercompany Dependencies Amounts owed to group undertakings of £95,298 suggest the company is part of a wider group structure (with Watson And Ewen Limited as the controlling entity). While this can provide financial support, it also creates dependency and means the company's financial health is interconnected with the group's overall position.
4. Director's Loan Outstanding Mr J N Whaley's director's loan account stands at £79,904 (down from £120,808). While the reducing trend is positive, this remains a significant sum. Director's loans can create tax implications under Section 455 (Corporation Tax Act 2009) – notably, there's a £58,673 S455 tax debtor shown, which relates to this loan. This effectively means the company has already paid tax on money still owed by the director.
5. Provisions for Liabilities £21,200 in provisions (down from £25,553) suggests anticipated future costs, possibly for dilapidations, warranties, or similar obligations. This is being managed down, which is positive.
6. Debtors Concentration Trade debtors of £193,466 (down from £257,472) shows improved collection, but combined with the director's loan of £79,904, total debtors represent a significant proportion of current assets. The reduction is a healthy sign.
4. Prognosis
Short-term Outlook (6-12 months): CAUTIOUSLY STABLE
The company has sufficient assets to cover its liabilities, and the improved cash position provides a small buffer. However, the thin working capital margin means any disruption – a major customer default, supply chain delay, or unexpected cost – could quickly create a liquidity crisis.
Medium-term Outlook (1-3 years): GUARDED BUT IMPROVING
The long-term trend of growing net assets is encouraging. If the company can: - Maintain the cash improvement trajectory - Continue reducing the director's loan - Manage stock levels more efficiently - Gradually reduce reliance on bank overdrafts
...then the prognosis improves significantly. The company has demonstrated over nearly 50 years of trading (incorporated 1976) that it can navigate economic cycles.
Risk Factors:
- Manufacturing sector pressures (input cost inflation, supply chain disruption)
- Dependency on group structure for financial support
- High stock levels in a potentially volatile market
- Interest rate exposure on bank debt
5. Recommendations
Immediate Actions (Critical)
1. Cash Flow Forecasting and Management Implement rolling 13-week cash flow forecasts to anticipate and prevent liquidity shortfalls. The historical volatility in cash balances (£1,414 to £49,134) suggests this is not currently being done effectively.
2. Stock Health Review Conduct an urgent stock aging analysis. With £328,578 in inventory (up 53%), management must determine: - What percentage is slow-moving or obsolete? - Is the increase driven by genuine demand forecasts or production inefficiencies? - Can stock levels be reduced through better procurement planning?
Target: Reduce stock by 15-20% (£50,000-£65,000) through active management, which would immediately improve the quick ratio.
3. Director's Loan Repayment Plan Establish a formal repayment schedule for the £79,904 director's loan. The S455 tax of £58,673 already paid on this loan represents locked-up capital. Clearing this loan would recover this tax and improve the company's working capital position.
Medium-term Actions (Important)
4. Debtor Management While trade debtors have reduced, implement stricter credit control procedures: - Shorten payment terms where possible - Offer early payment discounts - Consider invoice financing to accelerate cash collection
5. Creditor Management With trade creditors at £236,234, negotiate extended payment terms with key suppliers where possible, but avoid letting relationships deteriorate. Consider supply chain finance solutions.
6. Funding Structure Review The company should explore replacing short-term overdraft facilities (£157,628) with longer-term term loans. This would: - Reduce the risk of overdraft withdrawal - Provide more predictable repayment schedules - Potentially reduce interest costs
7. Group Structure Review Given the intercompany balance of £95,298 and the controlling entity (Watson And Ewen Limited), review whether group treasury management could optimise cash allocation across the group, potentially reducing external borrowing costs.
Long-term Actions (Strategic)
8. Working Capital Efficiency Targets Set specific KPI targets: - Current ratio: Aim for 1.5:1 minimum - Quick ratio: Aim for 1.0:1 minimum - Debtor days: Target reduction of 10% - Stock turnover: Establish baseline and target improvement
9. Profitability Analysis As the company files under the small companies regime, detailed profit and loss information is not publicly available. Internally, management should be monitoring gross margins, operating margins, and return on capital employed to ensure the business is generating adequate returns relative to the risks being taken.
10. Contingency Planning Develop a formal contingency plan for scenarios including: - Loss of a major customer - Supply chain disruption - Interest rate increases on bank debt - Economic downturn affecting demand
Summary Dashboard
| Metric | Current | Target | Status |
|---|---|---|---|
| Current Ratio | 1.28:1 | 1.5:1 | ⚠️ Below target |
| Quick Ratio | 0.69:1 | 1.0:1 | 🔴 Critical |
| Cash | £38,770 | £60,000+ | ⚠️ Improving |
| Stock % of Current Assets | 46% | <35% | 🔴 High |
| Leverage Ratio | 2.27:1 | <1.5:1 | 🔴 High |
| Net Asset Growth | £243,041 | Trend positive | 🟢 Healthy |
| Director's Loan | £79,904 | £0 | ⚠️ Reducing |